Literature DB >> 29046365

Amyloid PET scan: Staging beyond reading?

Gaël Chételat1, Melissa E Murray2.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 29046365     DOI： 10.1212/WNL.0000000000004678

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

1.  Neuropsychology and neuroimaging profiles of amyloid-positive versus amyloid-negative amnestic mild cognitive impairment patients.

Authors:  Clémence Tomadesso; Vincent de La Sayette; Robin de Flores; Pierrick Bourgeat; Victor L Villemagne; Stéphanie Egret; Francis Eustache; Gaël Chételat
Journal:  Alzheimers Dement (Amst)       Date:  2018-03-17

2.  In vivo staging of regional amyloid progression in healthy middle-aged to older people at risk of Alzheimer's disease.

Authors:  Fedor Levin; Irina Jelistratova; Tobey J Betthauser; Ozioma Okonkwo; Sterling C Johnson; Stefan J Teipel; Michel J Grothe
Journal:  Alzheimers Res Ther       Date:  2021-10-21       Impact factor: 8.823

Review 3.  Quantification of amyloid PET for future clinical use: a state-of-the-art review.

Authors:  Hugh G Pemberton; Lyduine E Collij; Fiona Heeman; Ariane Bollack; Mahnaz Shekari; Gemma Salvadó; Isadora Lopes Alves; David Vallez Garcia; Mark Battle; Christopher Buckley; Andrew W Stephens; Santiago Bullich; Valentina Garibotto; Frederik Barkhof; Juan Domingo Gispert; Gill Farrar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-04-07       Impact factor: 10.057
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.